Nexus Agriscience Acquires Biotech Institute Hemp Division IP Portfolio
January 27, 2026
Nexus Agriscience acquired the hemp division and associated intellectual property (IP) portfolio of Biotech Institute to expand its molecular farming platform. The deal includes issued and pending utility and plant patents, proprietary germplasm, seed inventory and living plant materials, with Biotech Institute leaders joining Nexus in governance and technical roles.
- Buyers
- Nexus Agriscience
- Targets
- Biotech Institute (hemp division and related hemp IP assets)
- Sellers
- Biotech Institute
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Cannabist Company Acquires Ciencia Labs Portfolio
December 11, 2024
Retail
The Cannabist Company (formerly Columbia Care) acquired the Ciencia Labs portfolio earlier in 2024 and is launching the Ciencia Labs brand dreamt in Maryland, with additional markets and products planned for 2025. The acquisition expands The Cannabist Company’s branded product offerings and supports broader retail and wholesale distribution across its dispensary and wholesale channels.
-
Paine Schwartz‑Backed HGS BioScience Acquires NutriAg Ltd.
November 5, 2025
Agriculture
HGS BioScience, a Paine Schwartz‑backed bionutritional platform, has acquired NutriAg Ltd., a Toronto‑based crop‑technology and bionutritionals company. The add‑on deal expands HGS’s North American footprint and R&D/capability set in biostimulants and crop nutrition; Cascadia advised on the transaction and financing.
-
NutraNomics to Acquire The Plant (DHS Development Inc.)
January 20, 2022
Manufacturing
NutraNomics, Inc. (OTC: NNRX), a Gladstone, Oregon-based nutraceuticals company, entered a binding letter of intent to acquire the assets, IP and key personnel of DHS Development Inc., doing business as The Plant, a contract cannabis processor in Desert Hot Springs, California. The acquisition is intended to expand NutraNomics’ processing, product diversity and R&D capabilities as part of its broader growth strategy; closing was targeted for February 2022 pending due diligence.
-
22nd Century Group Acquires RX Pharmatech Ltd
January 24, 2023
Food & Beverage
22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.
-
Invaio Sciences Acquires Peptyde Bio
December 7, 2023
Biotechnology
Invaio Sciences has acquired Peptyde Bio, a Danforth Technology Company spinout that discovers and designs antimicrobial peptides for crop protection. The deal brings Peptyde Bio’s peptide discovery platform and IP into Invaio’s AI-enabled discovery engine and biological delivery systems to accelerate nature-positive crop protection solutions.
-
PI Industries Acquires Plant Health Care Plc
November 24, 2025
Agriculture
In August 2024 PI Industries Ltd. acquired Plant Health Care Plc (PHC) and has integrated the business into its global agriculture arm, PI AgSciences. The acquisition expands PI's biologicals and sustainable crop solutions capabilities and brings PHC subsidiaries across the U.S., Brazil, Mexico and other markets into PI's global platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.